Plasma Immunoadsorption Therapy for Guillain-Barre Syndrome: Critical Day for Initiation.

Plasma immunoadsorption therapy for Guillain-Barré syndrome: critical day for initiation.

Immunoadsorption plasmapheresis (IAPP) is a method of removing circulating immune factors that is used to treat Guillain-Barré syndrome (GBS). We retrospectively analyzed the data on our GBS patients. In 21 patients treated with IAPP, linear regression analysis showed that the time from the onset of symptoms to the initiation of IAPP was correlated with the time required for improvement by one ...

The Guillain-Barre' syndrome.

Guillain-Barre’ Syndrome: A Case Report

Background and Objectives: Guillain-Barre´ Syndrome (GBS) is an acute-onset, monophasic, immune-mediated polyneuropathy that often follows an antecedent infection. Special nutritional support has an important role in these patients. Methods: A 6 years old girl with GBS was admitted to PICU of Dr. Sheikh Children Hospital (Mashhad, Iran). Chief compliance for hospitalization was inability to w...

Guillain-barre Syndrome

A case report is presented of a 33-year-old woman who awoke with distal paresthesias, mild incoordination, and progressive weakness. Examination 3 days later demonstrated weakness of the extremities, which was greater in distal muscles than in proximal ones! mild facial weakness, distal vibratory loss, and areflexia. Electrodiagnostic studies provided evidence of an acquired demyelinating polyr...

Prognosis in Guillain-Barre, syndrome

incomplete recovery in children with Guillain-Barrc polyneuritis. J Pediatr 1975;86:356-59. 3 Eisen A. Humphreys P. The Guillain-Barr6 syndrome. Arch Neurol 1974;30:438-43. 4 Asbury AK. Diagnostic considerations in Guillain-Barr6 syndrome. Ann Neurol 1981 ;9(Suppl): 1-15. 5 Marks HG, Augustine P, Allen RJ. Fisher's syndromc in children. Pediatrics 1977;60:726-9. " Kibel MA. Guillain-Barr6 syndr...